PHILADELPHIA As part of an effort to identify opportunities and gaps in biomedical research defined by the National Institutes of Health Roadmap for Medical Research, Jeremy M. Berg, director of the National Institute of General Medical Sciences, will discuss the role of chemists at the 228^th national meeting of the American Chemical Society, the worlds largest scientific society.

Dr. Berg will describe how chemists can work with biologists to impact progress in medical research by participating in the NIH roadmap project.

The NIH Roadmap for Medical Research is a framework of priorities designed to find new pathways to discovery, stimulate interdisciplinary research teams, and reshape clinical research to accelerate medical discovery and improve health.

The American Chemical Society is a nonprofit organization, chartered by the U.S. Congress, with a multidisciplinary membership of more than 159,000 chemists and chemical engineers. It publishes numerous scientific journals and databases, convenes major research conferences and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio.

'"/>


18-Aug-2004

Page: 1
Related biology news :

1. Illustrated guidebook published for Chinese biomedical scientists and students
2. Ottawas leadership in biomedical and health research has paid off
3. New world record magnet for chemical and biomedical research
4. Telescience recognized for facilitating biomedical research on a global network
5. Digital Biology Week: Building a national infrastructure for biomedical computing
6. New grants enable biomedical research centers to share science with their communities
7. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
8. UW-Madison scientists return to rat as biomedical research tool
9. Stanford biomedical ethicist speaks on role of race in scientific research
10. University of New Hampshire launches biomedical research network with $5.6 million grant
11. University of Pittsburgh scientist discusses blood cell damage from biomedical devices